April 24 | Tue Apr 24, 2012 4:26pm EDT
April 24 (Reuters) - Edwards Lifesciences Corp posted better-than-expected quarterly earnings on sales of a new heart valve, but the medical device maker said it now expects slower full-year sales due to a delay in U.S. approval of the product for an expanded group of patients.
The company on Tuesday reported first-quarter net earnings of $65.1 million, or 55 cents per share, compared with net income of $63.9 million, or 53 cents per share, a year ago.
Excluding special items, first-quarter earnings were 53 cents per share. Analysts on average had expected 48 c ents per share, according to Thomson Reuters I/B/E/S.
0 comments:
Post a Comment